Interacciones género y dósis dependientes entre el consumo de café y la actividad GGT en consumidores de alcohol

Referencias

Danielsson J, Kangastupa P, Laatikainen T, Aalto M, Niemelä O. Dose- and Gender-dependent Interactions between Coffee Consumption and Serum GGT Activity in Alcohol Consumers. Alcohol and Alcoholism Vol. 48, No. 3, pp. 303–307, 2013.

Agardh EE, Carlsson S, Ahlbom A et al. (2004) Coffee consumption,

type 2 diabetes and impaired glucose tolerance in Swedish
men and women. J Intern Med 255:645–52.
Alatalo PI, Koivisto HM, Hietala JP et al. (2008) Effect of moderate
alcohol consumption on liver enzymes increases with increasing
body mass index. Am J Clin Nutr 88:1097–103.
Alatalo PI, Koivisto HM, Hietala JP et al. (2009) Gender-dependent
impacts of body mass index and moderate alcohol consumption
on serum uric acid—an index of oxidant stress status? Free
Radic Biol Med 46:1233–8.
Arnesen E, Huseby NE, Brenn T et al. (1986) The Tromso Heart
Study: distribution of, and determinants for, gammaglutamyltransferase
in a free-living population. Scand J Clin Lab
Invest 46:63–70.
Bidel S, Hu G, Qiao Q et al. (2006) Coffee consumption and risk
of total and cardiovascular mortality among patients with type 2
diabetes. Diabetologia 49:2618–26.
Bidel S, Silventoinen K, Hu G et al. (2008) Coffee consumption,
serum gamma-glutamyltransferase and risk of type II diabetes.
Eur J Clin Nutr 62:178–85.
Breitling LP, Raum E, Müller H et al. (2009) Synergism between
smoking and alcohol consumption with respect to serum
gamma-glutamyltransferase. Hepatology 49:802–8.
306 Danielsson et al.
Downloaded from http://alcalc.oxfordjournals.org/ at Universidad de los Andes on September 4, 2013
Casiglia E, Spolaore P, Ginocchio G et al. (1993) Unexpected
effects of coffee consumption on liver enzymes. Eur J
Epidemiol 9:293–7.
Corrao G, Bagnardi V, Zambon A et al. (2004) A meta-analysis of
alcohol consumption and the risk of 15 diseases. Prev Med
38:613–9.
Costentin CE, Roudot-Thoraval F, Zafrani ES et al. (2011)
Association of caffeine intake and histological features of
chronic hepatitis C. J Hepatol 54:1123–9.
Dey A, Cederbaum AI. (2006) Alcohol and oxidative liver injury.
Hepatology 43:S63–S74.
Emdin M, Pompella A, Paolicchi A. (2005) Gammaglutamyltransferase,
atherosclerosis, and cardiovascular disease:
triggering oxidative stress within the plaque. Circulation
112:2078–80.
Floegel A, Pischon T, Bergmann MM et al. (2012) Coffee consumption
and risk of chronic disease in the European
Prospective Investigation into Cancer and Nutrition (EPIC)—
Germany study. Am J Clin Nutr 95:901–8.
Freedman ND, Everhart JE, Lindsay KL et al. (2009) Coffee intake
is associated with lower rates of liver disease progression in
chronic hepatitis C. Hepatology 50:1360–9.
Freedman ND, Park Y, Abnet CC et al. (2012) Association of
coffee drinking with total and cause-specific mortality. N Engl J
Med 366:1891–904.
Grassi F, Tell G, Robbie-Ryan M et al. (2007) Oxidative stress
causes bone loss in estrogen-deficient mice through enhanced
bone marrow dendritic cell activation. Proc Natl Acad Sci USA
104:15087–92.
Gressner OA (2009) Less Smad2 is good for you! A scientific
update on coffee’s liver benefits. Hepatology 50:970–8.
Gunzerath L, Faden V, Zakhari S et al. (2004) National Institute on
Alcohol Abuse and Alcoholism report on moderate drinking.
Alcohol Clin Exp Res 28:829–47.
Higdon JV, Frei B. (2006) Coffee and health: a review of recent
human research. Crit Rev Food Sci Nutr 46:101–23.
Hu G, Tuomilehto J, Pukkala E et al. (2008) Joint effects of coffee
consumption and serum gamma-glutamyltransferase on the risk
of liver cancer. Hepatology 48:129–36.
Huber WW, Scharf G, Rossmanith W et al. (2002) The coffee components
kahweol and cafestol induce gamma-glutamylcysteine
synthetase, the rate limiting enzyme of chemoprotective glutathione
synthesis, in several organs of the rat. Arch Toxicol
75:685–94.
Ikeda M, Maki T, Yin G et al. (2010) Relation of coffee consumption
and serum liver enzymes in Japanese men and women with
reference to effect modification of alcohol use and body mass
index. Scand J Clin Lab Invest 70:171–9.
Inoue M, Yoshimi I, Sobue T et al. (2005) Influence of
coffee drinking on subsequent risk of hepatocellular
carcinoma: a prospective study in Japan. J Natl Cancer Inst
97:293–300.
Kazemi-Shirazi L, Endler G, Winkler S et al. (2007) Gamma glutamyltransferase
and long-term survival: is it just the liver? Clin
Chem 53:940–6.
Kendrick SF, Day CP. (2007) A coffee with your brandy, sir?
J Hepatol 46:980–2.
Klatsky AL, Armstrong MA. (1992) Alcohol, smoking, coffee, and
cirrhosis. Am J Epidemiol 136:1248–57.
Klatsky AL, Morton C, Udaltsova N et al. (2006) Coffee, cirrhosis,
and transaminase enzymes. Arch Intern Med 166:1190–5.
Kozakova M, Palombo C, Eng MP et al. (2012) Fatty liver index,
gamma-glutamyltransferase, and early carotid plaques. Hepatology
55:1406–15.
Lança AJ, Israel Y. (1991) Histochemical demonstration of sinusoidal
gamma-glutamyltransferase activity by substrate protection
fixation: comparative studies in rat and guinea pig liver.
Hepatology 14:857–63.
Lee DH, Jacobs DR, Jr, Gross M et al. (2003) Gamma-glutamyltransferase
is a predictor of incident diabetes and hypertension:
the Coronary Artery Risk Development in Young Adults
(CARDIA) Study. Clin Chem 49:1358–66.
Lee DH, Blomhoff R, Jacobs DR, Jr. (2004) Is serum gamma glutamyltransferase
a marker of oxidative stress? Free Radic Res
38:535–9.
Lee DH, Ha MH, Kam S et al. (2006a) A strong secular trend in
serum gamma-glutamyltransferase from 1996 to 2003 among
South Korean men. Am J Epidemiol 163:57–65.
Lee DH, Silventoinen K, Hu G et al. (2006b) Serum gammaglutamyltransferase
predicts non-fatal myocardial infarction and
fatal coronary heart disease among 28,838 middle-aged men and
women. Eur Heart J 27:2170–6.
Leino A, Impivaara O, Irjala K et al. (1995) Health-based reference
intervals for ALAT, ASAT and GT in serum, measured according
to the recommendations of the European Committee for
Clinical Laboratory Standards (ECCLS). Scand J Clin Lab
Invest 55:243–50.
Mason JE, Starke RD, Van Kirk JE. (2010) Gamma-glutamyl transferase:
a novel cardiovascular risk biomarker. Prev Cardiol 13:36–41.
Mistry D, Stockley RA. (2010) Gamma-glutamyl transferase: the
silent partner? COPD 7:285–90.
Modi AA, Feld JJ, Park Y et al. (2010) Increased caffeine consumption
is associated with reduced hepatic fibrosis. Hepatology
51:201–9.
Nilssen O, Førde O, Brenn T. (1990) The Tromso Study.
Distribution and population determinants of gammaglutamyltransferase.
Am J Epidemiol 132:318–26.
Poikolainen K, Vartiainen E. (1997) Determinants of gammaglutamyltransferase:
positive interaction with alcohol and body
mass index, negative association with coffee. Am J Epidemiol
146:1019–24.
Ruhl CE, Everhart JE. (2005) Coffee and tea consumption are associated
with a lower incidence of chronic liver disease in the
United States. Gastroenterology 129:1928–36.
Ruttmann E, Brant LJ, Concin H et al. The Vorarlberg Health
Monitoring and Promotion Program Study Group. (2005)
Gamma-glutamyltransferase as a risk factor for cardiovascular
disease mortality: an epidemiological investigation in a cohort of
163,944 Austrian adults. Circulation 112:2130–7.
Ryu S, Chang Y, Woo HY et al. (2010) Longitudinal increase in
gamma-glutamyltransferase within the reference interval predicts
metabolic syndrome in middle-aged Korean men. Metabolism
59:683–9.
Shimazu T, Tsubono Y, Kuriyama S et al. (2005) Coffee consumption
and the risk of primary liver cancer: pooled analysis of two
prospective studies in Japan. Int J Cancer 116:150–4.
Speisky H, MacDonald A, Giles G et al. (1985) Increased loss and
decreased synthesis of hepatic glutathione after acute ethanol administration.
Turnover studies. Biochem J 225:565–72.
Tanaka K, Tokunaga S, Kono S et al. (1998) Coffee consumption
and decreased serum gamma-glutamyltransferase and aminotransferase
activities among male alcohol drinkers. Int J Epidemiol
27:438–43.
Targher G. (2010) Elevated serum gamma-glutamyltransferase activity
is associated with increased risk of mortality, incident type
2 diabetes, cardiovascular events, chronic kidney disease and
cancer—a narrative review. Clin Chem Lab Med 48:147–57.
Tverdal A, Skurtveit S. (2003) Coffee intake and mortality from
liver cirrhosis. Ann Epidemiol 13:419–23.
Tynjälä J, Kangastupa P, Laatikainen T et al. (2012) Effect of age
and gender on the relationship between alcohol consumption
and serum GGT: time to recalibrate goals for normal ranges.
Alcohol Alcohol 47:558–62.
Vitaglione P, Morisco F, Mazzone G et al. (2010) Coffee reduces
liver damage in a rat model of steatohepatitis: the underlying
mechanisms and the role of polyphenols and melanoidins.
Hepatology 52:1652–61.
The World Health Organization (1988) The World Health
Organization MONICA Project (Monitoring trends and determinants
in cardiovascular disease): a major international collaboration.
WHO MONICA Project Principal Investigators. J Clin
Epidemiol 41:105–14.
Zhang H, Forman HJ. (2009) Redox regulation of gamma-glutamyl
transpeptidase. Am J Respir Cell Mol Biol 41:509–15.